Wearables + Physical Therapy for Overactive Bladder in Multiple Sclerosis
(WeB Trial)

Recruiting in Palo Alto (17 mi)

Overseen byValerie J Block, DPTSc

Age: 18+

Sex: Female

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Waitlist Available

Sponsor: University of California, San Francisco

No Placebo Group

Trial Summary

What is the purpose of this trial?The goal is to investigate the feasibility and effects of adding "wearables for the bladder" devices to conventional pelvic floor physical therapy (PFPT) to bladder function, in people with multiple sclerosis (MS).

Eligibility Criteria

This trial is for California residents who were assigned female at birth, currently identify as female, have MS with mild to moderate bladder dysfunction but no recent treatments for it. Participants must be able to walk (with or without help), have a manual muscle test score of 2+, and own a smartphone with Wi-Fi at home.

Inclusion Criteria

California residents

Wifi in the home and personal smartphone (using Apple operating system)

I can walk by myself or with help from a device.

+4 more

Exclusion Criteria

Pregnancy

I have been treated for bladder problems in the last 3 months.

I have a urinary tract infection right now.

+2 more

Participant Groups

The study tests if adding 'wearables for the bladder' (WeB) devices to standard pelvic floor physical therapy can improve bladder function in people with multiple sclerosis. It's an in-home pilot study focusing on feasibility and effects.

2Treatment groups

Experimental Treatment

Active Control

Group I: WeB and pelvic floor physical therapy groupExperimental Treatment2 Interventions

This group will receive standard PFPT as well as WeB device for 12 weeks, and MS-symptom (including bladder bother) related questionnaires at baseline, 12 weeks and 6 months post intervention. Participants will also be provided with a remote activity monitor to use during the study.

Group II: Control pelvic floor physical therapy groupActive Control1 Intervention

This group will receive standard PFPT for 12 weeks. MS-symptom (including bladder bother) related questionnaires at baseline, 12 weeks and 6 months after the last PFPT visit. Patients will be invited to use WeB devices after this time.